Skip to main content

Design Therapeutics Inc. Common Stock (DSGN)

About The Company

DSGN Stock Market Logo

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

IPO Year Sector Industry
2021 Health Care Biotechnology: Pharmaceutical Preparations

Design Therapeutics Inc. (DSGN) Latest News

Company Contact & Address (DSGN)

Corporate Headquarters Phone Website
United States
+1 858 293-4900 Official DSGN Website

DSGN Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ DSGN

Jobs & Employment at Design Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Employment, Jobs & Careers at Design Therapeutics Inc. (DSGN)

Related & Similar Stock Symbols

CTRE Stock Market Price & News


CareTrust REIT Inc. Common Stock

FISI Stock Market Price & News


Financial Institutions Inc. Common Stock

NVT Stock Market Price & News


nVent Electric plc Ordinary Shares